BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 12110794)

  • 1. Prognostic significance of serum p53 antibody in patients with esophageal squamous cell carcinoma.
    Shimada H; Nabeya Y; Okazumi S; Matsubara H; Funami Y; Shiratori T; Hayashi H; Takeda A; Ochiai T
    Surgery; 2002 Jul; 132(1):41-7. PubMed ID: 12110794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perioperative changes of serum p53 antibody titer is a predictor for survival in patients with esophageal squamous cell carcinoma.
    Shimada H; Shiratori T; Takeda A; Matsushita K; Okazumi S; Akutsu Y; Matsubara H; Nomura F; Ochiai T
    World J Surg; 2009 Feb; 33(2):272-7. PubMed ID: 19052812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of high serum p53 antibody titers in patients with esophageal squamous cell carcinoma.
    Suzuki T; Yajima S; Ishioka N; Nanami T; Oshima Y; Washizawa N; Funahashi K; Otsuka S; Nemoto T; Shimada H
    Esophagus; 2018 Oct; 15(4):294-300. PubMed ID: 29959634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum p53 antibody is a useful tumor marker in superficial esophageal squamous cell carcinoma.
    Shimada H; Takeda A; Arima M; Okazumi S; Matsubara H; Nabeya Y; Funami Y; Hayashi H; Gunji Y; Suzuki T; Kobayashi S; Ochiai T
    Cancer; 2000 Oct; 89(8):1677-83. PubMed ID: 11042560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of anti-p53 and anti-KRas circulating antibodies in esophageal cancer patients treated with chemoradiotherapy.
    Blanchard P; Quero L; Pacault V; Schlageter MH; Baruch-Hennequin V; Hennequin C
    BMC Cancer; 2012 Mar; 12():119. PubMed ID: 22448886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum p53 antibodies as a prognostic indicator in oral squamous cell carcinoma.
    Yamazaki Y; Chiba I; Ishikawa M; Satoh C; Notani K; Ohiro Y; Totsuka Y; Mizuno S; Kitagawa Y
    Odontology; 2008 Jul; 96(1):32-7. PubMed ID: 18661202
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritherapeutic Serum p53 Antibody Titers are Predictors of Survival in Patients with Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Chemotherapy and Surgery.
    Yamashita K; Makino T; Tanaka K; Yamasaki M; Yamamoto M; Miyazaki Y; Takahashi T; Kurokawa Y; Nakajima K; Takiguchi S; Mori M; Doki Y
    World J Surg; 2017 Jun; 41(6):1566-1574. PubMed ID: 28108772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of serum p53 antibodies in patients with resected non-small cell lung cancer.
    Laudanski J; Burzykowski T; Niklinska W; Chyczewski K; Furman M; Niklinski J
    Lung Cancer; 1998 Dec; 22(3):191-200. PubMed ID: 10048472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of serum p53 antibodies is associated with decreased in vitro chemosensitivity in patients with esophageal cancer.
    Shimada H; Okazumi S; Takeda A; Nabeya Y; Matsubara H; Funami Y; Hayashi H; Gunji Y; Suzuki T; Ochiai T
    Surg Today; 2001; 31(7):591-6. PubMed ID: 11495153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum p53 antibodies in mucosal esophageal cancer and negative conversion after treatment.
    Shimada H; Arima M; Nakajima K; Koide Y; Okazumi S; Matsubara H; Miyazawa Y; Takeda A; Hayashi H; Yoshida T; Ochiai T; Isono K
    Am J Gastroenterol; 1998 Aug; 93(8):1388-9. PubMed ID: 9707082
    [No Abstract]   [Full Text] [Related]  

  • 11. p53 serum antibodies as prognostic indicator in head and neck cancer.
    Werner JA; Gottschlich S; Folz BJ; Goeroegh T; Lippert BM; Maass JD; Rudert H
    Cancer Immunol Immunother; 1997 Apr; 44(2):112-6. PubMed ID: 9177473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of serum p53 antibodies in patients with esophageal squamous cell carcinoma: correlation with clinicopathologic features and tumor markers.
    Shimada H; Nakajima K; Ochiai T; Koide Y; Okazumi SI; Matsubara H; Takeda A; Miyazawa Y; Arima M; Isono K
    Oncol Rep; 1998; 5(4):871-4. PubMed ID: 9625835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Value of Serum p53 Antibody in the Diagnosis and Prognosis of Esophageal Squamous Cell Carcinoma.
    Kunizaki M; Hamasaki K; Wakata K; Tobinaga S; Sumida Y; Hidaka S; Yasutake T; Miyazaki T; Matsumoto K; Yamasaki T; Sawai T; Hamamoto R; Nanashima A; Nagayasu T
    Anticancer Res; 2018 Mar; 38(3):1807-1813. PubMed ID: 29491120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating anti-p53 antibodies in esophageal cancer patients.
    Kozłowski M; Kovalchuk O; Nikliński J; Chyczewski L; Starosławska E; Ciechański A; Dabrowski A; Niklińska W; Dziegielewski P; Lapuć G; Wallner G; Laudański J
    Folia Histochem Cytobiol; 2001; 39 Suppl 2():173-4. PubMed ID: 11820593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of circulating anti-p53 antibodies in esophageal cancer patients.
    Hagiwara N; Onda M; Miyashita M; Sasajima K
    J Nippon Med Sch; 2000 Apr; 67(2):110-7. PubMed ID: 10754600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The presence of anti-p53 antibodies in sera from patients with oesophageal carcinoma: correlation to treatment, tumour volume and survival.
    Bergström S; Dreilich M; Wagenius G; Brattström D; Larsson A; Hesselius P; Bergqvist M
    In Vivo; 2004; 18(5):615-20. PubMed ID: 15523902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preoperative serum immunoglobulin G and A antibodies to Porphyromonas gingivalis are potential serum biomarkers for the diagnosis and prognosis of esophageal squamous cell carcinoma.
    Gao SG; Yang JQ; Ma ZK; Yuan X; Zhao C; Wang GC; Wei H; Feng XS; Qi YJ
    BMC Cancer; 2018 Jan; 18(1):17. PubMed ID: 29298684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum p53 antibody as a potential tumor marker in extrahepatic cholangiocarcinoma.
    Okada R; Shimada H; Otsuka Y; Tsuchiya M; Ishii J; Katagiri T; Maeda T; Kubota Y; Nemoto T; Kaneko H
    Surg Today; 2017 Dec; 47(12):1492-1499. PubMed ID: 28508195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year postsurgical monitoring of serum p53 antibody for locally advanced esophageal squamous cell carcinoma.
    Kochi R; Yajima S; Nanami T; Suzuki T; Oshima Y; Tokura N; Takatsuka J; Funahashi K; Tochigi N; Shimada H
    Clin J Gastroenterol; 2018 Aug; 11(4):278-281. PubMed ID: 29497977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment response and prognosis of patients after recurrence of esophageal cancer.
    Shimada H; Kitabayashi H; Nabeya Y; Okazumi S; Matsubara H; Funami Y; Miyazawa Y; Shiratori T; Uno T; Itoh H; Ochiai T
    Surgery; 2003 Jan; 133(1):24-31. PubMed ID: 12563234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.